Please try another search
Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited. As of September 29, 2023, Suven Pharmaceuticals Limited operates as a subsidiary of Berhyanda Limited.
Name | Age | Since | Title |
---|---|---|---|
Govinda Prasad Dasu | 72 | - | Independent & Non-Executive Director |
Vetukuri Venkata Naga Kali Vara Prasada Raju | - | 2023 | MD & Director |
Vaidheesh Annaswamy | - | 2023 | Executive Chairman |
Stefan Stoffel | 58 | 2023 | Member of Advisory Council |
Kumarapuram Gopalakrishnan Ananthakrishnan | - | 2023 | Independent Director |
Shweta Jalan | 48 | 2023 | Non-Executive Director |
Vinod Rao | 61 | 2023 | Independent Director |
Matangi Gowrishankar | 66 | 2023 | Independent Director |
Pravin Udhyavara Bhadya Rao | 63 | 2023 | Independent Director |
Pankaj Patwari | - | 2023 | Non-Executive Director |
Venkateswarlu Jasti | 75 | 2019 | Member of Advisory Council |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review